Vitamin K2, honestly — plausible, promising, unproven

Vitamin K2 is a favourite of the longevity-supplement world with a genuinely interesting mechanism — and thin proof. Activating calcium-related proteins does not establish that a supplement prevents fractures or cardiovascular events, and K2 is not an automatic companion to vitamin D.

The mechanism people get excited about

Vitamin K2 (menaquinone) activates proteins involved in bone mineralisation and inhibition of vascular calcification. That is a plausible mechanism, but a change in a protein or imaging marker is not the same as preventing a fracture, heart attack or stroke.

A plausible mechanism, though, is a starting point, not proof.

What the evidence shows

A real signal, mostly observational.

• Higher K2 intake tracks with less heart disease — In a large cohort, people with the highest dietary K2 intake had lower coronary heart-disease death and less arterial calcification — while vitamin K1 showed no such link. Encouraging, but observational. (emerging)
• Plausible role in bone — K2 is involved in bone-building proteins, and some studies suggest a benefit for bone density — though, as with the heart, the strong human proof isn’t there yet. (emerging)

Why it’s not proven

• Randomised trials are small and mixed — Trials testing whether K2 supplements actually slow arterial calcification have been inconsistent — some in kidney-disease patients failed to show benefit. The cohort signal hasn’t been confirmed by convincing randomised evidence. (note)
• No routine recommendation — There is no established routine indication to add K2 to vitamin D or to use it for cardiovascular or fracture prevention in healthy adults. Vitamin K can materially interfere with vitamin-K-antagonist anticoagulation. (note)

What we still don’t know

• Does K2 supplementation prevent heart disease? The observational signal is promising, but no convincing randomised trial has yet shown supplements reduce cardiovascular events.
• The right form and dose Different K2 forms (MK-4 vs MK-7) behave differently, and the optimal dose for any benefit is unsettled.

Key terms

• Vitamin K2 A family of menaquinones that activate vitamin-K-dependent proteins; a mechanism is not proof of clinical benefit from supplementation.
• Arterial calcification Calcium build-up in artery walls. Some K2 studies measure calcification or related proteins, but prevention of clinical events remains unproven.
• Matrix Gla protein A K2-dependent protein that helps keep calcium out of artery walls.
• MK-7 A long-acting form of vitamin K2 commonly used in supplements.